No benefit of rivaroxaban in COVID outpatients: PREVENT-HDNovember 11, 2022ThrombosisCOVID-19 UpdatesStroke
Combo thrombolytic approach fails to reduce ICH in strokeNovember 3, 2022StrokeThrombosisInterventional Cardiology & Surgery
Best anticoagulant for minimizing bleeding risk identifiedNovember 1, 2022Arrhythmias & EPPreventive CareThrombosis
Collateral flow flags stroke patients for late thrombectomyOctober 31, 2022StrokeInterventional Cardiology & SurgeryThrombosis
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart diseaseOctober 18, 2022StrokeArrhythmias & EPThrombosisPreventive Care
New deep dive into Paxlovid interactions with CVD medsOctober 17, 2022Lipid DisordersCOVID-19 UpdatesAcute Coronary SyndromesArrhythmias & EPCAD & AtherosclerosisHeart FailureHypertension
Amulet, Watchman 2.5 LAAO outcomes neck and neck at 3 yearsSeptember 23, 2022Interventional Cardiology & SurgeryArrhythmias & EPStrokeThrombosis
A week of anticoagulation halves post-PCI radial occlusion rateSeptember 20, 2022Interventional Cardiology & SurgeryAcute Coronary SyndromesCAD & AtherosclerosisThrombosis
New ESC guidelines for cutting CV risk in noncardiac surgerySeptember 15, 2022Acute Coronary SyndromesPreventive CareHeart FailureArrhythmias & EPStrokeThrombosis
Rivaroxaban outmatched by VKAs for AFib in rheumatic heart diseaseAugust 28, 2022Arrhythmias & EPHeart FailureStrokeThrombosisMixed Topics
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in strokeAugust 28, 2022StrokeThrombosisCAD & AtherosclerosisLipid DisordersHypertension
Low-dose edoxaban curbs stroke risk in elderly with AF, despite frailtyAugust 25, 2022Arrhythmias & EPHeart FailureThrombosisStroke
Updates on treatment/prevention of VTE in cancer patientsAugust 9, 2022ThrombosisVenous ThromboembolismPreventive CareCOVID-19 Updates